Researchers recently investigated the safety of apremilast in pediatric patients with psoriasis. Read what they discovered in this article.
Study shows measurement of early ustekinumab levels could be used to direct treatment strategy in psoriasis.
Researchers in Taiwan investigated whether behavioral modifications such as weight reduction, alcohol abstinence, smoking cessation and exercise could impact psoriasis severity. Read what they discovered in this article.
Discover key takeaways from the American Academy of Dermatology and National Psoriasis Foundation joint guidelines for the management and treatment of psoriasis with phototherapy published in the September issue of the Journal of American Academy of Dermatology.
About one-third of patients with psoriasis are children or adolescents. Still, little research exists on treating this patient population. New disease management guidelines and emerging studies seek to fill the gap.
When George Martin, M.D., was doing his dermatology residency at UCLA in the mid-1980s, psoriasis was considered a disorder of keratinization.
Do you recommend psychotherapy to your psoriasis patients? While there is a well-established connection between psoriasis and mental health, there is little data available on the impact of psychological interventions on psoriasis. These study authors look to fill that gap.
There are more treatment options for psoriasis patients than ever before, so why do patient reported outcomes still suggest failure to meet patient expectations? Experts from the International Psoriasis Council (IPC) highlight factors that could be causing the perceived disparity between psoriasis treatment and patient satisfaction.
Psoriasis patients with skin of color experience psoriasis differently, often reporting worse health related quality of life outcomes compared to their Caucasian peers. Brodalumab may help, suggests a recent study.
The evaluation of psoriasis requires more than simply checking the severity and spread of the disease, a new report suggests. Rather, physicians should try to distinguish between stable and active disease with an eye toward the wider body-wide effects of the latter form.